Premium
Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high‐grade metastatic tumor with rhabdoid and focal neuroendocrine features
Author(s) -
Hoppmann Anna,
Williams Adele P.,
Coleman Aubrey,
Tynes Clay,
Williams Grant R.,
MroczekMusulman Elizabeth,
Aye Jamie,
Whelan Kimberly F.,
Clay Michael R.,
Ranganathan Sarangarajan,
Beierle Elizabeth A.
Publication year - 2020
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.28048
Subject(s) - medicine , atezolizumab , carboplatin , etoposide , oncology , neuroendocrine tumors , chemotherapy , cancer , cisplatin , nivolumab , immunotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom